CoChat

A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care

Open access

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Exome (ES) or genome (GS) sequencing are recommended as first- or second-tier molecular tests for patients with developmental disorders (DD), but the clinical utility of GS continues to be debated. METHODS: This prospective randomized trial involving all Belgian human genetics centers compared the standard of care (SoC) - combining ES and chromosomal microarray analysis or shallow GS - with GS for 567 individuals with unexplained DD. The study was retrospectively registered. RESULTS: The diagnostic yield of GS was 39.8% (113/284) vs. 30% for SoC (85/283) (p = 0.015), mainly due to an increased detection of single nucleotide variants and indels (+ 8.7%). GS also enabled the detection of three non-coding (potential) pathogenic variants. Across both study arms, the diagnostic yield was higher for females (45.5%, 97/213) compared to males (28.5%, 101/354) (p < 0.001). Upon correction for the sex distribution and analytical differences between the study arms, the diagnostic yield difference between GS and SoC was reduced to 7.3% (p = 0.069). De novo variants were found for 23.6% of patients. Analysis of inherited variants in genes associated with autosomal dominant phenotypes contributed more to the diagnostic yield (3.9%) than X-linked variants (1.9%), and to a similar extent as autosomal recessive variants (4.1%). CONCLUSIONS: This nationwide study indicates GS outperforms SoC for the diagnosis of patients with DD in a decentralized hospital setting and well-characterized cohort. The results also highlight the importance of evaluating autosomal dominant inherited variants in genomics analyses for DD. TRIAL REGISTRATION: ClinicalTrials.gov (NCT07051213, 03-07-2025).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-026-01771-2

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 3

  1. Immacolata Spagnuolo M, López-Bueno R, Kosremelli Asmar M, et al. Global prevalence of developmental disabilities in children and adolescents: a systematic umbrella review. Front Public Health. Published online 2023. https://vizhub.healthdata.org/gbd-results/.
  2. Gross AM, Ajay SS, Rajan V, et al. Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease. Published online. 2018. https://doi.org/10.1038/s41436. · doi:10.1038/s41436
  3. Nurk S, Koren S, Rhie A, et al. The complete sequence of a human genome. Sci (1979). 2022;376:44–53. https://www.science.org.

Cited by

See all 1

Metadata

Authors
Geysens, M., Souche, E., Baroni, M. C., Benoit, V., Beyltjens, T., Bossuyt, W., Bours, V., Crabbé, M., Croes, D., De Smet, M., Désir, J., Devriendt, K., Dheedene, A., Dimitrov, B. I., Janssens, K., Kumps, C., Lumaka, A., Menten, B., Meuwissen, M., Monestier, O., Mortier, G., Olsen, C., Palmeira, L., Peeters, H., Pölsler, L., Revencu, N., Roland, D., Soblet, J., Sznajer, Y., Taziaux, S., Van Esch, H., Vandeweyer, G., Vantroys, E., Vilain, C., Wiame, E., Van Den Bogaert, K., & Vermeesch, J. R.
Affiliations
  • Universitair Ziekenhuis Leuven (BE)
  • University of Antwerp (BE)
  • Centre Hospitalier Universitaire de Liège (BE)
  • Cliniques Universitaires Saint-Luc (BE)
  • Institute of Pathology and Genetics (BE)
  • Ghent University Hospital (BE)
  • Vrije Universiteit Brussel (BE)
  • Université Libre de Bruxelles (BE)
Corresponding author
Vermeesch, Joris Robert
Venue
Genome Medicine
Published
2026-10-05
Volume
18
Issue
1
ISSN
1756-994X (ISSN-L)
OpenAlex
W7219642533
Cited by
0
References
57
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Genome Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders
  • KU Leuven (C1-C14/22/125)
  • Fonds Wetenschappelijk Onderzoek (T-003819N)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
developmental disorders, genome sequencing, diagnostic yield, standard of care comparison, genetic diagnosis
MeSH terms
Whole Genome Sequencing, Exome Sequencing, Child, Developmental Disabilities, Child, Preschool, Female, Genetic Testing, Humans, Male, Prospective Studies, Genome, Human, Standard of Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care. https://app.cochat.ai/papers/10.1186/s13073-026-01771-2
The paper
Geysens, M., Souche, E., Baroni, M. C., Benoit, V., Beyltjens, T., Bossuyt, W., Bours, V., Crabbé, M., Croes, D., De Smet, M., Désir, J., Devriendt, K., Dheedene, A., Dimitrov, B. I., Janssens, K., Kumps, C., Lumaka, A., Menten, B., Meuwissen, M., . . . Vermeesch, J. R. (2026). A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care. Genome Medicine. https://doi.org/10.1186/s13073-026-01771-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.